NEK7 (NEK7) (C-Term) Peptid
NEK7
Reaktivität: Human, Ratte
Wirt: Synthetic
BP, WB
-
- Target Alle NEK7 Produkte
- NEK7
- Protein Region
- C-Term
- Spezies
- Human, Ratte
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- EQCDYPPLPS DHYSEELRQL VNICINPDPE KRPDIAYVYD VAKRMHACTA
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-Nek7 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- NEK7
- Synonyme
- 2810460C19Rik Peptide, AU020186 Peptide, wu:fj68f02 Peptide, zgc:100962 Peptide, zgc:92175 Peptide, AtNek7 Peptide, NIMA-related kinase 7 Peptide, NIMA (never in mitosis gene a)-related expressed kinase 7 Peptide, NIMA-related kinase 7 Peptide, NIMA related kinase 7 Peptide, NIMA-related kinase 7 S homeolog Peptide, Nek7 Peptide, nek7 Peptide, NEK7 Peptide, nek7.S Peptide
- Hintergrund
-
Nek7 is a protein kinase which plays an important role in mitotic cell cycle progression. It is required for microtubule nucleation activity of the centrosome, robust mitotic spindle formation and cytokinesis. Nek7 phosphorylates RPS6KB1.
Alias Symbols: -
Protein Size: 302 - Molekulargewicht
- 33 kDa
- Gen-ID
- 360850
- NCBI Accession
- NM_001108346, NP_001101816
- UniProt
- D3ZBE5
-
Sie sind hier:
